Search This Blog

Thursday, November 7, 2019

Flexion Therapeutics EPS misses by $0.03, beats on revenue

Flexion Therapeutics (NASDAQ:FLXN): Q3 GAAP EPS of -$1.00 misses by $0.03.
Revenue of $21.79M (+211.7% Y/Y) beats by $2.78M.
Shares -0.9%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)